• Physicians, paraproteins and progress: diagnosis and management of myeloma. 

  Pawlyn, C; Jackson, GH (2019-02-02)

  Myeloma outcomes have improved dramatically over the last decade as a result of novel therapies, several of which are now commonly continued to disease relapse. Physicians who do not work in haematology are therefore more ...
• Labelled chemical probes for demonstrating direct target engagement in living systems 

  Collins, I; Prevet, H
• Dependence of inertial cavitation induced by high intensity focused ultrasound on transducer F-number and nonlinear waveform distortion. 

  Khokhlova, T; Rosnitskiy, P; Hunter, C; Maxwell, A; Kreider, W; Ter Haar, G; Costa, M; Sapozhnikov, O; Khokhlova, V

  Pulsed high intensity focused ultrasound was shown to enhance chemotherapeutic drug uptake in tumor tissue through inertial cavitation, which is commonly assumed to require peak rarefactional pressures to exceed a certain ...
• ESR1 mutations in metastatic lobular breast cancer patients. 

  Desmedt, C; Pingitore, J; Rothé, F; Marchio, C; Clatot, F; Rouas, G; Richard, F; Bertucci, F; Mariani, O; Galant, C; Fribbens, C; O'Leary, B; van den Eynden, G; Salgado, R; Turner, NC; Piccart, M; Vincent-Salomon, A; Pruneri, G; Larsimont, D; Sotiriou, C (2019)

  Invasive lobular breast cancer (ILC) represents the second most common histology of breast cancer after invasive ductal breast cancer (IDC), accounts for up to 15% of all invasive cases and generally express the estrogen ...
• Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer. 

  Vyse, S; Huang, PH

  Inframe insertions of three or more base pairs in exon 20 of the epidermal growth factor receptor (EGFR) gene were among the first EGFR mutations to be identified as oncogenic drivers in non-small cell lung cancer (NSCLC). ...

View more